Bliss GVS Pharma informs about standalone financial results

12 Feb 2016 Evaluate

Bliss GVS Pharma has informed about standalone financial results and standalone limited review for the period ended December 31, 2015.

The above information is a part of company’s filings submitted to BSE.

Bliss GVS Pharma Share Price

154.90 1.20 (0.78%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×